In vogue with venture.

摘要

What types of life science enterprises are attracting venture capitalists today? The current financial and regulatory environment is posing challenges to investors and entrepreneurs in the healthcare sector. Fewer dollars are going into venture capital and fewer venture capital companies have money to invest. There is a dearth of pharmaceutical acquisitions, the traditional exit for healthcare investors. The pace of pharmaceutical deals has slowed, and the deals that are getting done are often structured buyouts (Box 1). Although initial public offerings have been happening, only a select few companies have attained expected valuations. Coupled with political pressure to emphasize drug safety and ever more stringent regulatory hurdles, life science enterprises are faced with several challenges due to the current market environment.